MFDS — authorised 30 August 2007
- Marketing authorisation holder: IPSEN PHARMA
- Status: likely_approved
🇰🇷 Somatuline Depot in South Korea
MFDS authorised Somatuline Depot on 30 August 2007
Marketing authorisation
Somatuline Depot in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in South Korea
Frequently asked questions
Is Somatuline Depot approved in South Korea?
Yes. MFDS authorised it on 30 August 2007.
Who is the marketing authorisation holder for Somatuline Depot in South Korea?
IPSEN PHARMA holds the South Korean marketing authorisation.